IGC Pharma (IGC) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	939.29K
Accounts receivable, net of allowances	653.96K
Inventories	58.65K
Advance taxes
Prepaid expenses and other current assets	1.27M
Total current assets	2.92M
Goodwill	198.17K
Property, plant and equipment, net	6.93M
Investments in affiliates	2.6M
Investments-others	5.23M
Restricted cash
Other non-current assets	504.07K
Total assets	18.86M
Short-term borrowings	0
Trade payables
Accrued expenses	90.05K
Notes payable	1.8M
Other current liabilities	517.25K
Total current liabilities	2.86M
Other non-current liabilities	150.75K
Total liabilities	4.04M
Shares potentially subject to rescission rights (4,868,590 shares issued and outstanding)
Common stock — $.0001 par value; 75,000,000 shares authorized; 16,091,843 issued and outstanding as of June 30, 2011 and 14,890,181 issued and outstanding as of March 31, 2011	2.4K
Additional paid-in capital	67.82M
Accumulated other comprehensive income	-2.31M
Retained earnings (Deficit)	-51.11M
Non-controlling interest	420.63K
Total stockholders' equity	14.4M
Total liabilities and stockholders' equity	18.86M

Entities mentioned with IGC

View All Entities